Dr Mark Fendrick Explains Bipartisan Appeal of Value-Based Insurance Design

Reasons to Attend Patient-Centered Oncology Care® 2021 in September

Dr Peter McAllister Discusses Lessons Learned From COVID-19 for Migraine Treatment

Dr Rigmor Jensen Considers the Future of Research on Medication Overuse Headache

Dr Frank Porreca Talks Through the Challenges of Measuring Migraine Pain

Dr Peter McAllister Explains the Economic Benefits of Migraine Prevention

Dr Stephen Silberstein On the Next Steps for Anti-CGRP Therapies

Dr Faraidoon Haghdoost Discusses Next Steps for COVID-19, Migraine Research

Dr Rigmor Jensen Dispels Common Misconceptions About Medication Overuse Headache

Dr Frank Porreca Shares His Thoughts on Green Light Therapy for Migraine

Dr Patricia Coyle on Considerations in Choosing a DMT for MS

Dr Peter McAllister Shares How COVID-19 Altered Patients' Migraine Symptoms

Dr Ruth Ann Marrie on Comorbidities Affecting MS Treatment Decisions

Dr Patricia Coyle on Escalation vs High-Efficacy Induction in MS

Dr Stephen Silberstein Discusses Erenumab Use for Menstrual Migraine

Dr Anne Reihman: AntiIL-5 Therapies Can Be Life-Changing for Patients With Eosinophilic Asthma

Dr Ruth Ann Marrie Discusses Comorbidities in Multiple Sclerosis

Dr Frank Porreca: How Advancements CGRP Inhibitors Paved the Way for Migraine Prevention Therapies

Dr Michael Green Explains the Link Between Monocyte-Like Cells, Neurotoxicity After CAR T Therapy

Dr Jill Jarecki Discusses Whether Gender Affects SMA Severity

Dr J. Allen Meadows Discusses Adherence to Biologics for Asthma

Assessing Employer Influence on Workplace Mental Health

Dr John Corboy on Probing Patient Quality of Life Off MS Medication

Dr Bhuvana Sagar on Payment Reform in Oncology

Dr Lalan Wilfong Talks Employer Involvement in Cancer Care Benefits

Dr Faraidoon Haghdoost Explains Results of COVID-19 Migraine Triggers, Frequency Study

Dr Barbara McAneny on Issues With Step Therapy and Home Infusion in Oncology

Dr Lucio Gordan on Telehealth and New Health Care Models in COVID-19

Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials

Dr Shweta Bansal Explains Factors Associated With Increased Screening, Recognition of CKD

Bo Gamble Previews COA Payer Exchange Summit 2020

Dr Kunihiro Matsushita Discusses Alternative Endpoints for Clinical Trials on Kidney Disease

Dr Mark Fendrick Previews COA Payer Summit V-BID Discussion

Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney Disease

Dr Andre Goy Discusses Potential Benefits of Earlier Use of CAR T Therapies

Dr Jill Jarecki Discusses the Early SMA Treatment for Infants

Dr Aditya Bardia Forecasts What’s to Come for the ASCENT Trial in Triple-Negative Breast Cancer

Researchers Use GWAS to Identify Novel Loci Associated with Kidney Function

Racial Disparities in Acute Care Utilization Rates Among Children With Glomerular Disease

Dr Benjamin Griffin Identifies Risk Factors Associated With Hospital Readmission Following AKI

Dr Guofen Yan On the Mechanism Behind Racial Disparities in ESKD Incidence

Dr Aimee Tharaldson Outlines the Pipeline, Role of Emerging Specialty Medications

Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD

This Week in Managed Care: October 23, 2020

Dr Michael Green Discusses Understanding Patient Response to CAR T-Cell Therapy

Dr Susan Millard on the Choosing Wisely Campaign, Pediatric Sleep Recommendations

Melissa Andel on Legislative Efforts, Unmet Needs for State-Level Prescription Drug Pricing Reform

Dr Lametra Scott Discusses Cost, Formulary Guidance in Managing Sickle Cell Disease

Dr Anne Reihman Talks Unraveling the Mystery of Patients Who Do Not Respond to Anti-IL-5 Treatment

How Collaboration Between Pharmacists of Health Plans, Systems Can Drive Value-Based Payment Models

Dr Anthony Loschner: Artificial Intelligence Can Benefit Underserved Populations

Dr J. Allen Meadows Outlines New Long-term Safety, Efficacy Data for Dupilumab in Asthma

Dr Shweta Bansal Highlights Lack of Screening, Diagnoses of CKD

Dr Peter McAllister on How COVID-19 Has Impacted Migraine Prevention Efforts

Dr J. Allen Meadows on Using Shared Decision Making to Choose Among Biologics for Asthma

Dr Nicola Hanania: Patient, Clinician Collaboration Is Key to Choosing Optimal Biologic Therapy

Examining Payer Strategies, Impact on Managing Specialty Medications

Dr Megan Althoff on the Difficulties Deciding Between Biologics for Patients With Severe Asthma

Dr David Jackman on Dana Farber's Clinical Pathway Development Process